Product News
Immunosyn Releases Wound Healing Photographs From The First Phase “Proof Of Concept Trial” In Europe For Treatment Of Diabetic Ulcers With Biopharmeceutical Sf-1019
February 27, 2008
Immunosyn Announces The Successful Completion
of First Phase “Proof of Concept Trial” in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
January 17, 2008
Immunosyn Announces Biozyme Lab’s Receipt of MHRA Manufacturing License Approval
in Europe
for the Biopharmaceutical SF-1019
November 28, 2007
Immunosyn Corporation Releases SF-1019 Study Results
November 08, 2007
Argyll Biotechnologies Retains Becker & Associates
November 06, 2007
Immunosyn Corporation Signs Expanded License Agreement
October 25, 2007
